MwanzoVALN • NASDAQ
add
Valneva SE
Bei iliyotangulia
$ 8.95
Bei za siku
$ 8.78 - $ 8.91
Bei za mwaka
$ 3.62 - $ 12.25
Thamani ya kampuni katika soko
759.28M USD
Wastani wa hisa zilizouzwa
elfu 21.01
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
TipRanks
siku 1 iliyopita
Valneva Reports Positive Phase 2 Results for Chikungunya Vaccine in Children
2.56%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 29.41M | -35.82% |
Matumizi ya uendeshaji wa biashara | 15.56M | 13.89% |
Mapato halisi | -44.36M | -380.24% |
Kiwango cha faida halisi | -150.82 | -648.12% |
Mapato kwa kila hisa | -0.26 | -72.17% |
EBITDA | -31.96M | -326.31% |
Asilimia ya kodi ya mapato | -2.03% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 143.46M | -8.23% |
Jumla ya mali | 448.23M | -13.24% |
Jumla ya dhima | 297.75M | -0.47% |
Jumla ya hisa | 150.48M | — |
hisa zilizosalia | 181.05M | — |
Uwiano wa bei na thamani | 10.78 | — |
Faida inayotokana na mali | -20.28% | — |
Faida inayotokana mtaji | -25.59% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -44.36M | -380.24% |
Pesa kutokana na shughuli | -17.44M | -66.39% |
Pesa kutokana na uwekezaji | elfu 197.00 | 101.28% |
Pesa kutokana na ufadhili | elfu -556.00 | -101.07% |
Mabadiliko halisi ya pesa taslimu | -17.84M | -171.60% |
Mtiririko huru wa pesa | -16.25M | 39.99% |
Kuhusu
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
700
